For this purpose, we performed in vivo immunoprecipitation using anti-c-Myc antibody in the cancerous tissue from an advanced colitis-associated cancer (CAC, a subtype of CRC) patient under stage IV. The gene discussed is MYC; the disease is colorectal carcinoma.